InvestorsHub Logo

caddiedad

02/22/22 12:48 AM

#371390 RE: ramfan60 #371389

Perhaps the chatter back in 2020 about V being effective for Covid patients will produce the goods after all with April’s late breaker Mitigate data?

couldbebetter

02/22/22 7:01 AM

#371393 RE: ramfan60 #371389

Ramfan60, My wild speculation on this topic would be that Vascepa
"could be" part of the solution to some of the issues caused by Covid
and/or the vaccine. However, Vascepa will not be taken seriously unless
a BP (such as Pfizer) owns it and then demands that the government pay
for its use (like they have done for Pfizer's Covid Vaccination.)
Simply put, Vascepa is not even on the radar for this important issue.
Why? Because BP does not own it so there is nobody of any consequence
to push for its use. Amarin management does not seem to have a clue
in that regard. I am hoping that Dr. Alex Denner has more than a clue.